Home page > About us
extra small siz normal size extra large size

Edit email address
Invalid email
Email Sent
Authorize the processing of personal data

About us


Improving the lives of people with acute, rare and chronic disorders.

Chiesi USA, Inc., headquartered in Cary, NC, is an affiliate of Chiesi Farmaceutici S.p.A, a family-owned, global R&D-focused pharmaceutical company based in Parma, Italy. We are a specialty pharmaceutical company committed to the development and commercialization of products for the hospital, rare diseases and adjacent specialty care settings. As an organization, we have a strong track record of performance. This has allowed the company to grow quickly in terms of sales, people, and product portfolio. With revenues exceeding $478 million in 2022, Chiesi USA has quickly established itself as a top-producing affiliate in the Chiesi Group.

Our primary focus is on people: the people we serve in the healthcare community; the people whose lives are touched by our products and services; and the people who work at Chiesi USA, as they strive to build their company, their family and their community.


Chiesi is a sustainable pharmaceutical company committed to generating economic value in a way that also benefits society by addressing its needs and challenges, thus connecting the company’s success with social progress. We are dedicated to people, patients, and the planet. Together, we strive to have a lasting positive impact on patients, customers, and in the communities where we live and work. This is achieved by operating with empathy, integrity, and respect in a socially and environmentally responsible manner. Learn more about how we make sustainability more tangible through our employee-led corporate social responsibility program, Chiesi in the Community, and our status as a Public Benefit Corporation and Certified B Corporation.



Headquartered in Parma, Italy, Chiesi Farmaceutici is an international, research focused healthcare group with over 85 years of experience in the pharmaceutical industry. The Chiesi Group researches, develops and markets innovative drugs in three specific areas: AIR (products and services in the respiratory field, from infants to adults), RARE (innovative solutions and personalized services to improve the quality of life of patients with rare and ultra-rare diseases) and CARE (products and services to support specialist care, personal care and well-being).

The Chiesi Group spans the globe, employing more than 6,500 people in 31 affiliates worldwide. Therapeutic solutions are distributed in over 100 countries.

With a consolidated turnover of 2 billion and 749 million euros, The Chiesi Group is among the top 50 pharmaceutical companies in the world. The Group's Research and Development is based in Parma and integrates with six other major research centers in France, the United States, Canada, China, the United Kingdom and Sweden, to promote its preclinical, clinical and regulatory programs. Production plants are located in Parma (Italy), Blois (France) and Santana de Parnaiba (Brazil).

image bottom